Forth Photonics

Forth Photonics is a medical device company that designs, develops, manufactures and markets imaging systems focusing on the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions.

Forth Photonics has developed a proprietary technology platform that has the potential to address a number of diseases affecting millions of people worldwide and costing billions of dollars to healthcare systems.

The first product introduced to the market is DySIS^TM, which focuses on assisting the non-invasive in vivo detection and diagnosis of cancerous and pre-cancerous lesions of the cervix. DySIS^TM provides advanced tools to aid medical practitioners in detection, grading, and documentation of cervical neoplasia.

DySIS^TM is CE-marked in Europe, and its ability to provide significantly improved performance argues strongly for its adoption as the standard of care in colposcopy.

Structure

Forth Photonics comprises two companies:
Forth Photonics Ltd, based in Edinburgh, UK (global headquarters)
Forth Photonics Hellas SA, based in Athens, Greece (R&D and manufacturing)

Vision

To be the global leader in automated optical molecular imaging technologies for medical diagnostic and screening applications.

Mission

Forth Photonics is committed to saving human lives through the early detection and diagnosis of disease using biophotonic innovations.